Hjem › Myelodysplastiske syndromer › New York › New York City
Kliniske studier for Myelodysplastiske syndromer i New York City, NY
21 studier for Myelodysplastiske syndromer søker deltakere på steder i og rundt New York City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekruttererFase 2
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
RekruttererFase 1
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
RekruttererFase 1
- Memorial Sloan Kettering Cancer Center, New York
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RekruttererFase 1/2
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
- Montefiore, New York
Cord Blood Transplant in Adults With Blood Cancers
RekruttererFase 2
- Memorial Sloan Kettering Cancer Center, New York
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
RekruttererFase 3
- MSKCC, New York
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
RekruttererFase 1
- NYU Langone Health, New York
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
RekruttererFase 1/2
- Ichan School of Medicine at Mount Sinai, New York
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
RekruttererFase 1/2
- Research Site, New York
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
RekruttererFase 2
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
RekruttererFase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
RekruttererFase 2/3
- Perlmutter Cancer Center - 34th Street, New York
- Icahn School of Medicine at Mount Sinai, New York
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
RekruttererFase 1
- Icahn School of Medicine at Mount Sinai, New York
Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes
RekruttererFase 1
- Memorial Sloan Kettering Cancer Center, New York
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
RekruttererFase 1
- New York University, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, New York
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
RekruttererFase 1
- Memorial Sloan Kettering Cancer Center, New York
Study of REM-422 in Patients With AML or Higher Risk MDS
RekruttererFase 1
- Memorial Sloan Kettering, New York
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
RekruttererFase 1
- Memorial Sloan Kettering Cancer Center, New York
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
RekruttererFase 1
- Memorial Sloan-Kettering Cancer Center, New York
Myelodysplastiske syndromer-studier i andre byer
- Houston, TX43 studier
- Baldwin Park, CA26 studier
- Seattle, WA21 studier
- Washington, DC20 studier
- Tampa, FL19 studier
- Boston, MA19 studier
- Miami, FL17 studier
- Durham, NC14 studier
- Columbus, OH14 studier
- St. Louis, MO13 studier
- Atlanta, GA13 studier
- Chicago, IL13 studier
Andre studier i New York City
- Brystkreft136 studier
- Ikke-småcellet lungekreft121 studier
- Kreft (alle typer)109 studier
- Prostatakreft103 studier
- Metastatisk kreft93 studier
- Kolorektal kreft78 studier
- Eggstokkreft69 studier
- Lungekreft60 studier
- Multipelt myelom60 studier
- Pankreaskreft60 studier
- Endometriekreft52 studier
- Akut myelogen leukemi51 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.